Pharmaceutical company Zydus Cadila will likely apply for emergency use authorization to India’s central drugs regulator for its COVID-19 vaccine ZyCoV-D next week, stated official sources.

Once the vaccine is approved, it will become the worlds first DNA vaccine against COVID-19 and the fourth vaccine to be available in India. According to an official source, the analysis of data from the phase-three trial is almost complete and the company has informed the government that it will likely seek emergency use authorization for its vaccine in the coming week. The vaccine is also being tested on children in the 12 to 18 years age group, besides adults… (NDTV – PTI, June 18, 2021)